• Molecular NameNilotinib
  • SynonymAMN-107; AMN107; nilotinib
  • Weight529.526
  • Drugbank_IDDB04868
  • ACS_NO641571-10-0
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)4.97
  • pkaN/A
  • LogD (pH=7, predicted)4.93
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-6.6
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.0
  • No.of HBond Donors2
  • No.of HBond Acceptors8
  • No.of Rotatable Bonds7
  • TPSA97.1
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA tyrosine kinase inhibitor.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability30.0
  • Protein binding98.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life17 h
  • Excretionbiliary
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A